Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Non-Current Debt (2019 - 2024)

Historic Non-Current Debt for Regen BioPharma (RGBPP) over the last 3 years, with Q1 2024 value amounting to $143685.0.

  • Regen BioPharma's Non-Current Debt changed N/A to $143685.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $143685.0, marking a year-over-year change of. This contributed to the annual value of $149614.0 for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Regen BioPharma's Non-Current Debt stood at $143685.0.
  • In the past 5 years, Regen BioPharma's Non-Current Debt registered a high of $153981.0 during Q4 2023, and its lowest value of $143685.0 during Q1 2024.